Abstract
Purpose Golden retriever muscular dystrophy (GRMD) is a widely used canine model of Duchenne muscular dystrophy (DMD). Recent studies have shown that magnetic resonance imaging (MRI) can be used to non-invasively detect consistent changes in both DMD and GRMD. In this paper, we propose a semiautomated system to quantify MRI biomarkers of GRMD.
Methods Our system was applied to a database of 45 MRI scans from 8 normal and 10 GRMD dogs in a longitudinal natural history study. We first segmented six proximal pelvic limb muscles using a semiautomated full muscle segmentation method. We then performed preprocessing, including intensity inhomogeneity correction, spatial registration of different image sequences, intensity calibration of T2-weighted and T2-weighted fat-suppressed images, and calculation of MRI biomarker maps. Finally, for each of the segmented muscles, we automatically measured MRI biomarkers of muscle volume, intensity statistics over MRI biomarker maps, and statistical image texture features.
Results The muscle volume and the mean intensities in T2 value, fat, and water maps showed group differences between normal and GRMD dogs. For the statistical texture biomarkers, both the histogram and run-length matrix features showed obvious group differences between normal and GRMD dogs. The full muscle segmentation showed significantly less error and variability in the proposed biomarkers when compared to the standard, limited muscle range segmentation.
Conclusion The experimental results demonstrated that this quantification tool could reliably quantify MRI biomarkers in GRMD dogs, suggesting that it would also be useful for quantifying disease progression and measuring therapeutic effect in DMD patients.
Similar content being viewed by others
References
Moser H (1984) Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention. Hum Genet 66:17–40
Hoffman EP, Brown RH Jr, Kunkel LM (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51:919–928
Koenig M, Hoffman EP, Bertelson CJ, Monaco AP, Feener C, Kunkel LM (1987) Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50:509–517
Bulfield G, Siller WG, Wight PA, Moore KJ (1984) X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci USA 81:1189–1192
Gaschen FP, Hoffman EP, Gorospe JR, Uhl EW, Senior DF, Cardinet GH 3rd, Pearce LK (1992) Dystrophin deficiency causes lethal muscle hypertrophy in cats. J Neurol Sci 110:149–159
Kornegay JN, Tuler SM, Miller DM, Levesque DC (1988) Muscular dystrophy in a litter of golden retriever dogs. Muscle Nerve 11:1056–1064
Cooper BJ, Winand NJ, Stedman H, Valentine BA, Hoffman EP, Kunkel LM, Scott MO, Fischbeck KH, Kornegay JN, Avery RJ, Williams JR, Schmickel RD, Sylvester JE (1988) The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs. Nature 334:154–156
Kornegay JN, Bogan JR, Bogan DJ, Childers MK, Li J, Nghiem P, Detwiler DA, Larsen CA, Grange RW, Bhavaraju-Sanka RK, Tou S, Keene BP, Howard JF Jr, Wang J, Fan Z, Schatzberg SJ, Styner MA, Flanigan KM, Xiao X, Hoffman EP (2012) Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies. Mamm Genome 23:85–108
Kobayashi M, Nakamura A, Hasegawa D, Fujita M, Orima H, Takeda S (2009) Evaluation of dystrophic dog pathology by fat-suppressed T2-weighted imaging. Muscle Nerve 40:815–826
Thibaud JL, Monnet A, Bertoldi D, Barthelemy I, Blot S, Carlier PG (2007) Characterization of dystrophic muscle in golden retriever muscular dystrophy dogs by nuclear magnetic resonance imaging. Neuromuscul Disord 17:575–584
Yokota T, Lu QL, Partridge T, Kobayashi M, Nakamura A, Takeda S, Hoffman E (2009) Efficacy of systemic morpholino exon-skipping in Duchenne dystrophy dogs. Ann Neurol 65:667–676
Lamminen AE (1990) Magnetic resonance imaging of primary skeletal muscle diseases: patterns of distribution and severity of involvement. Br J Radiol 63:946–950
Lovitt S, Moore SL, Marden FA (2006) The use of MRI in the evaluation of myopathy. Clin Neurophysiol 117:486–495
Marden FA, Connolly AM, Siegel MJ, Rubin DA (2005) Compositional analysis of muscle in boys with Duchenne muscular dystrophy using MR imaging. Skeletal Radiol 34:140–148
Liu GC, Jong YJ, Chiang CH, Jaw TS (1993) Duchenne muscular dystrophy: MR grading system with functional correlation. Radiology 186:475–480
Karpati G, Ajdukovic D, Arnold D, Gledhill RB, Guttmann R, Holland P, Koch PA, Shoubridge E, Spence D, Vanasse M, Watters GV, Abrahamowicz M, Duff C, Worton RG (1993) Myoblast transfer in Duchenne muscular dystrophy. Ann Neurol 34: 8–17
Miller RG, Sharma KR, Pavlath GK, Gussoni E, Mynhier M, Lanctot AM, Greco CM, Steinman L, Blau HM (1997) Myoblast implantation in Duchenne muscular dystrophy: the San Francisco study. Muscle Nerve 20:469–478
Mathur S, Lott DJ, Senesac C (2010) Age-related differences in lower-limb muscle cross-sectional area and torque production in boys with Duchenne muscular dystrophy. Arch Phys Med Rehabil 91:1051–1058
Kornegay JN, Cundiff DD, Bogan DJ, Bogan JR, Okamura CS (2003) The cranial sartorius muscle undergoes true hypertrophy in dogs with golden retriever muscular dystrophy. Neuromuscul Disord 13:493–500
Childers MK, Okamura CS, Bogan DJ, Bogan JR, Sullivan MJ, Kornegay JN (2001) Myofiber injury and regeneration in a canine homologue of Duchenne muscular dystrophy. Am J Phys Med Rehabil 80:175–181
Wang J, Fan Z, Kornegay J, Styner M (2011) MRI-based quantification of Duchenne muscular dystrophy in a canine model. Proc SPIE Med Imaging 7965:79650G1–79650G9
Yushkevich PA, Piven J, Hazlett HC, Smith RG, Ho S, Gee JC, Gerig G (2006) User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage 31:1116–1128
Hou Z (2006) A review on MR image intensity inhomogeneity correction. Proc Int J Biomed Imaging 2006:49515-1–49515-11
Tustison NJ, Avants BB, Cook PA, Zheng Y, Egan A, Yushkevich PA, Gee JC (2010) N4ITK: improved N3 bias correction. IEEE Trans Med Imaging 29:1310–1320
Sled JG, Zijdenbos AP, Evans AC (1998) A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging 17:87–97
Kim HK, Laor T, Horn PS, Racadio JM, Wong B, Dardzinski BJ (2010) T2 mapping in Duchenne muscular dystrophy: distribution of disease activity and correlation with clinical assessments. Radiology 255:899–908
Pluim JP, Maintz JB, Viergever MA (2003) Mutual-information-based registration of medical images: a survey. IEEE Trans Med Imaging 22:986–1004
Perona P, Malik J (1990) Scale-space and edge detection using anisotropic diffusion. IEEE Trans Pattern Anal Mach Intell 12: 629–639
Chuah TK, Poh CL, Sheah K (2011) Quantitative texture analysis of MRI images for detection of cartilage-related bone marrow edema. Proc IEEE Eng Med Biol Soc 2011:5112–5115
Mayerhoefer ME, Schima W, Trattnig S, Pinker K, Berger-Kulemann V, Ba-Ssalamah A (2010) Texture-based classification of focal liver lesions on MRI at 3.0 Tesla: a feasibility study in cysts and hemangiomas. J Magn Reson Imaging 32:352–359
Holli K, Laaperi AL, Harrison L, Luukkaala T, Toivonen T, Ryymin P, Dastidar P, Soimakallio S, Eskola H (2010) Characterization of breast cancer types by texture analysis of magnetic resonance images. Acad Radiol 17:135–141
Zhang J, Yu C, Jiang G, Liu W, Tong L (2012) 3D texture analysis on MRI images of Alzheimer’s disease. Brain Imaging Behav 6:61–69
Herlidou S, Rolland Y, Bansard JY, Le Rumeur E, De Certaines JD (1999) Comparison of automated and visual texture analysis in MRI: characterization of normal and diseased skeletal muscle. Magn Reson Imaging 17:1393–1397
Mahmoud-Ghoneim D, Cherel Y, Lemaire L, De Certaines JD, Maniere A (2006) Texture analysis of magnetic resonance images of rat muscles during atrophy and regeneration. Magn Reson Imaging 24:167–171
Galloway M (1975) Texture analysis using gray level run lengths. Comput Graph Imaging Proc 4:172–179
Bryk AS, Raudenbush SW (1992) Hierarchical linear models: applications and data analysis methods. Sage, Newbury Park
Tegeler C, Grange R, Bogan D, Markert C, Case D, Kornegay J, Childers M (2010) Eccentric contractions induce rapid isometric torque drop in dystrophic-deficient dogs. Muscle Nerve 42:130–132
Childers M, Bogan J, Bogan D, Greiner H, Holder M, Grange R, Kornegay J (2011) Chronic administration of a leupeptin-derived calpain inhibitor fails to ameliorate severe muscle pathology in a canine model of Duchenne muscular dystrophy. Front Pharmacol 2:89
Abramoff M, Magalhaes P, Ram S (2004) Image processing with image J. Biophoton Intern 11:36–42
Acknowledgments
This work was supported by National Institutes of Health Grant Nos. R42 NS059095-03 (NINDS) (Styner), P30-HD003110-41 (NICHD) (Styner) and 1U24NS059696-01A1 (NINDS) (Kornegay), the Muscular Dystrophy Association (Kornegay), Wellstone center for Muscular Dystrophy Research [USPHS (NIAMS) 1U54AR056953-01], The North Carolina Translational and Clinical Sciences (NC TraCS) Institute [Tracs50K (50KR71104)] and UNC Intellectual and Developmental Disabilities Research Center. The authors thank Weili Lin and Kathleen Wilber for their help in acquisition of MRI scans and their helpful discussions, Hongtu Zhu and Mihye Ahn for their helpful discussions on the statistical analysis, and Janet and Dan Bogan, and Jennifer Dow for technical assistance in managing the dogs. Conflict of interest The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, J., Fan, Z., Vandenborne, K. et al. A computerized MRI biomarker quantification scheme for a canine model of Duchenne muscular dystrophy. Int J CARS 8, 763–774 (2013). https://doi.org/10.1007/s11548-012-0810-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11548-012-0810-6